Cai, Hongmin http://orcid.org/0000-0001-7221-8330
Guo, Shimeng http://orcid.org/0000-0002-8086-5092
Xu, Youwei http://orcid.org/0000-0001-8069-7511
Sun, Jun
Li, Junrui
Xia, Zhikan
Jiang, Yi http://orcid.org/0000-0002-0723-1413
Xie, Xin http://orcid.org/0000-0003-2314-4800
Xu, H. Eric http://orcid.org/0000-0002-6829-8144
Funding for this research was provided by:
National Natural Science Foundation of China (32130022)
Article History
Received: 17 October 2023
Accepted: 22 March 2024
First Online: 16 April 2024
Competing interests
: H.E.X. is the founder and chairman of the board of Cascade Pharmaceutics. The remaining authors declare no competing interests.